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Abstract 
Health-related information design has made a difference to people’s lives through clear 
explanation of procedures, processes, disease prevention and maintenance. This paper 
provides an example of user-centered design being applied to engage people with the 
prevention of drug-resistant infection. In particular, we focus on antibiotic resistance in the 
specific location of a community pharmacy in Rwanda. We describe an information 
campaign, Beat Bad Microbes, and summarize the challenges and opportunities of working 










Health-related information design has made a difference to people’s lives through clear 
explanation of procedures, processes, disease prevention and maintenance. There is 
historical precedence for this, for example, in the work of Otto and Marie Neurath and their 
application of Isotype principles to health concerns, such as TB and leprosy (Walker, 2019); 
as well as many excellent examples of contemporary relevance (e.g., Noel et al., 2017; van der 
Waarde, 2014) and in related design specialisms including human factors and ergonomics 
(e.g., Hignett et al., 2017), and service design (e.g., Chamberlain et al., 2017).  
This paper provides an example of user-centered design being applied to engage 
people with the prevention of drug-resistant infection, in particular, antibiotic resistance, in 
the specific location of a community pharmacies in Rwanda. As well as describing an 
information campaign, Beat Bad Microbes, it summarizes the challenges and opportunities 
of working in Rwanda on a cross-disciplinary project in which design research and practice 
are closely integrated. The user-centered design methods here included co-design, making of 
prototypes, the application of information design good practice, and evaluation of materials 
by intended users in context.  
 
2. An ‘equitable partnership’ 
The Beat Bad Microbes project was underpinned by partnership working that enabled 
contributions of cross- and inter-disciplinary expertise, research and professional in 
information design and pharmacy; and institutional collaboration between universities 
(University of Reading and University of Rwanda), and with professional organizations 
(Rwanda Community Pharmacists Union (RCPU) and the Commonwealth Pharmacists 
Association (CPA)). This was driven to some extent by the requirements of the funding for 
the work -- the University of Reading’s Global Challenges Research Fund (GCRF) allocation 
for equitable partnerships. The funding defined that we work with partners and distribute 
the funding to benefit researchers and research users in an LMIC country. However, our 
commitment to involving information stakeholders and users in developing ideas for 
effective use of language and images was inherently well-aligned with the notion of ‘equitable 
partnership’. For communication in community pharmacies to be effective we needed to find 
out about how Rwandan pharmacies operated and how pharmacists worked: we wanted to 
gauge current levels of understanding amongst pharmacists about antibiotic resistance; we 
were keen to know how prescriptions were dispensed and what kind of interaction there was 
between pharmacists and their patients. We wanted to understand why people visit 
pharmacies and whether or not they expected to receive advice about their health. These 
issues underpinned co-design workshops with the expectation that researchers, project 
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partners and intended users worked together to consider ways of using community 
pharmacies to raise public awareness of antibiotic resistance. 
Our academic project partner, the School of Pharmacy, University of Rwanda, 
provided information about perceptions of antimicrobial resistance in Rwanda and 
contributions to workshops, practical support through locations for workshops and advice 
and support for ethics, and ideas for project legacy including future collaborations. The CPA 
played a key role in the project through providing a summary overview of the extent of AMR 
awareness in Rwanda and neighboring countries in Africa (Tuck et al., 2018). RCPU was 
fundamental to the success of the work through engaging its member network to become 
involved in the workshops as co-researchers; and providing locations for and people to 
undertake the testing of materials in our pilot study. We worked with RCPU president, 
Flandrie Habyarimana, to organize a meeting with teachers, children and others in his home 
village.  
 
3. The origins of Beat Bad Microbes 
BBM derived from a previous cross-disciplinary project ‘Information Design and 
Architecture in Persuasive Pharmacy Space: combating AMR’ (IDAPPS) which considered 
how the socially inclusive and convenient environment of community pharmacies could be 
used to raise awareness of antimicrobial resistance and specifically misuse of antibiotics. 
IDAPPS brought together academics and practitioners in information design, architecture, 
behavioral psychology and pharmacy. The project affirmed the relevance of partnership 
working, co-design and prototype review as key ingredients in successful and innovative 
communication design (Walker et al., 2020).  
One aim of the IDAPPS project was to draw attention to the role of design -- 
information design, user-centered design, architecture and interior design -- in 
communicating information about anti-microbial resistance in community pharmacies. We 
were aware that for many people involved in public health communication, design is 
something that is considered at the end of a project to make materials or products look good, 
or to align with particular brand guidelines (see Black & Stanbridge, 2012). We wanted to 
demonstrate that design can be a catalyst for innovative thinking – and the IDAPPS method 
included a competition (supported by a 2-day ‘Ideas Lab’) where cross-disciplinary teams 
worked to design ways to help people understand the threat of anti-microbial resistance. One 
outcome from the IDAPPS competition was an installation and materials for use in a 
community pharmacy in Reading, UK. Under the slogan ‘Beat Bad Bugs’, life-size characters 
– the ‘persuaders’ – offered a perspective on antibiotic usage. These messages were 
reinforced through leaflets, worksheets, and badges for distribution by pharmacy staff. 
Initial feedback to the prototype installation suggested that, with some adaptions, this 
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approach worked well to engage people with issues around AMR and antibiotic misuse. 
(Figure 1) 
 
Figure 1. Prototype materials for ‘Beat Bad Bugs’ on display for user evaluation in a pharmacy in Reading, UK. 
 
The ‘Beat Bad Bugs’ materials were seen by the CPA who thought this solution and way 
of working could be of value in their work in Africa. This stimulated discussion and led to a 
proposal for funding from Reading’s GCRF allocation, introduced above. The research in 
Rwanda set out to: 
 assess current initiatives/schemes and state of AMR and antimicrobial stewardship 
in Rwanda through interviews with pharmacists in Rwanda to identify factors unique 
to the Rwanda environment which can influence the delivery of AMR interventions; 
 conduct co-design workshops (along the lines of the IDAPPS Ideas Lab) to develop 
approaches to the design of the materials for use in a Rwandan context; 
 evaluate pharmacist, pharmacy worker and pharmacy visitor reactions to the 
materials developed in the workshops, using the qualitative measures used in the 
IDAPPS project. 
 
4. Workshops: developing Beat Bad Bugs for Rwanda 
The research comprised two user-centered, co-design workshops at the University of 
Rwanda, and a meeting with members of a local community. The aim of the workshops was 
first, to produce a design brief, and secondly, to gather feedback on prototype designs. 
Participants included pharmacists, pharmacy academics and business owners, CPA 
representatives, design and communication specialists and researchers. We used co-design 
methods to engage all participants.  
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The rationale for the workshops derived from the IDAPPS project in the UK. The 
evaluation of the Beat Bad Bugs installation in the Reading pharmacy suggested that many 
pharmacy users were ‘passive’ in relation to the display, responding only to parts of the 
intervention that they happened to encounter. Beyond reading the texts on some of the 
standing figures, there was little engagement with, for example, leaflets, badges and feedback 
forms. Many of the pharmacy users affirmed that clear action points in simple, 
straightforward language was important. This and other feedback reported by Walker et al., 
2020, informed questions for consideration in the workshops in Rwanda, including: 
 
 What kinds of intervention might gain attention in a Rwandan pharmacy setting? 
 To what extent might life-size characters (as used in Beat Bad Bugs) resonate with 
Rwandan pharmacy users? If the response to this is favourable, what characters are 
likely to be relevant? What names, what appearance, what ‘antibiotic message’ should 
they carry? 
 How much information in any one message can people take in? How do people 
perceive text presented as a) continuous text; b) list structures with bullets etc 
 Should messages be explanatory or directive? 
 How should characters (or other interventions) be positioned in pharmacy space?  Is 
there typically a waiting area? Is this a good place to position material that needs to 
be read? 
 How can related elements be drawn together (if that is relevant)? 
 What is likely to be the baseline understanding of AMR, specifically antibiotic 
resistance? 
 What other health-related campaigns are people aware of? 
 Is it good/ helpful to have a name for a set of interventions? Does ‘getting the 
message across’ to individuals benefit from a campaign name, or do people respond 
better to a message they can relate to individually? 
 
4.1. First workshop: producing a design brief 
The prototype materials were developed in collaboration with pharmacists and pharmacy 
users at the first workshop. After being shown the outcomes of the IDAPPS project, small 
groups considered the kind of intervention that might work in pharmacies in Rwanda, the 
messages that could be usefully conveyed and how they might be expressed in words and 
pictures. Participants sketched and drew their ideas, which included ways in which antibiotic 
resistance might be explained, or images that might represent microbes. We used role play to 
anticipate pharmacist/patient interaction in a pharmacy. As with the IDAPPS work in the 
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UK, workshop participants visited pharmacies in Kigali to gain understanding of the 
environment in which the materials would be used. Working with a design consultancy, 
Design Science (who had also facilitated the first workshop in Rwanda), we produced first 
prototypes for the visual identity for the campaign and for a set of materials. Materials were 
drafted first in English, taking account of guidance on clear writing summarized in Kools 
(2012), and translated into Kinyarwanda by members of RCPU to ensure pharmacy 
practitioner accuracy in meaning. This work comprised: 
 
Visual identity. Members of the first workshop wanted to take forward the Beat Bad Bugs 
identity from the IDAPPS project. It was thought to be distinctive, appropriate and would be 
highly visible among the visual clutter in Rwandan community pharmacies. (Figure 2) 
 
Figure 2. Part of the visual identity for ‘Beat Bad Bugs’ as supported by participants at workshop 1 in Rwanda. 
 
Antibiotic record card. An ‘antibiotic record card’ was proposed by workshop participants 
for patients to keep track of the antibiotics they take, and to help dispensing pharmacists 
(and/or prescribers) to be aware of the antibiotics a patient has taken in the past, and any 
reactions they may have had to particular antibiotics. (Figure 3) 




Figure 3. First iteration of the Antibiotic Record Card. 99 x 148 mm 
 
Information about antibiotics. Influenced by the information cards from the IDAPPS 
project, a set of laminated cards was made. The set was divided into two. Blue-banded cards 
were to remind pharmacists about AMR including ‘What is antibiotic resistance’ and ‘ 
Antibiotics don’t work for a virus’; and, for patients, green-banded cards to provide 
information about taking antibiotics: ‘Do you need antibiotics?’, ‘Concerns about side 
effects’, ‘Completing the course’ and ‘Taking antibiotics with or without food’. (Figure 4) 
 
Figure 4. Examples from the pack of laminated information cards for use in community pharmacies in 
Rwanda. Blue-banded cards with information for pharmacists, green-banded cards with information for 
patients. 210 x 148 mm 
 
4.2. Second workshop: feedback from stakeholders 
The first set of materials was reviewed by pharmacists and members of the public as part of a 
second workshop in Rwanda, and by community members at a village meeting. Interest was 
high, the pharmacists commenting that this was the first time they had been part of a project 
where their views played a substantive role. They acknowledged that consideration of 
circumstances of use, and the needs of users were important components of design and that 
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they had the skills and expertise to contribute. A meeting with members of a local 
community in a village school affirmed the need for raising public awareness of AMR. As a 
result of feedback from both meetings: 
 ‘Beat Bad Bugs’ became ‘Beat Bad Microbes’ because despite the alliterative appeal of 
the former, the word ‘bugs’ was not widely used in Rwanda. It was revealing to see 
how the word ‘microbes’ was used by adults and children alike by attendees at our 
village workshop, and affirmed the value of being aware of local terminology;  
 the symbol of a hand and the colour green were thought by pharmacists and 
members of the public to be distinctive and appropriate; there was a suggestion that 
visual representation of some form of pill would enhance the message. The shape of 
the pill to be used was drawn and discussed in the workshop where it was agreed that 
a capsule shape was widely used for antibiotic dispersal in Rwanda; 
 the antibiotic card stimulated much discussion and while thought to be a positive 
intervention, the A6 format was too big to store and handle. The purpose of the card 
was agreed to be: for patients, to keep track of the antibiotic they take; for dispensing 
pharmacists (and prescribers), to be aware of the antibiotics a patient has taken in 
the past, and any reactions they may have had to particular antibiotics; 
 pharmacists thought that the set of laminated information cards was confusing to use 
but they agreed that the information for patients would be useful; 
 it was agreed that having the materials available in Kinyarwanda and in English was 
essential to reach as wide and audience as possible. While Kinyarwanda is the first 
language, project partner RCPU advised that pharmacists used English professionally 
as well as being widely used in the community. There was also support for a French 
version (but no funding is available for this currently). 
 
Taking account of this feedback, a revised set of materials in English and Kinyarwanda was 
produced by the research team.  
 
Visual identity. The Beat Bad Bugs identity was revised to become Beat Bad Microbes and 
the device changed so that the open hand contains a pill capsule. Green continued to be used 
as the overall campaign color, with blue used to differentiate pharmacist-facing information 
as appropriate. (Figure 5) 




Figure 5. Device for ‘Beat Bad Microbes’ modified from ‘Beat Bad Bugs’ taking account of feedback from 
Rwandan users. 
 
Antibiotic record card. Workshop discussions confirmed that the antibiotic record card was 
the key component of Beat Bad Microbes. The participants proposed what should be 
recorded on the cards (for adults): 
 
Information about the card holder 
 Name 
 ID 
 Have you taken antibiotics in the last 3 months? 
 Are you pregnant? 
 Are you breast feeding? 
 How old are you? 
 Are you allergic to any medicines? If yes, write down what they are or tell your 
pharmacist 
 Pharmacy contact details 
 Doctor contact details 
 
Information about each ‘antibiotic encounter’ 
 Date 
 Condition 
 Name and brand of antibiotic 
 Did you have any side effects? 
 How long did it take you to feel better? 
 Did you complete the course? 
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The antibiotic record card was redesigned in a smaller format that would be easy to carry 
around. In the card, a short text and an illustration were developed to explain the purpose of 
the card and to provide context for the reader. Color was used to distinguish the information 
to be filled-in by pharmacists (in blue), and by patients (in green). (Figure 6) 
 
Figure 6. The antibiotic record card redesigned in a smaller format, with new content. Show here with labels 
used to explain to workshop participants the design decisions taken to make the information clear and 
accessible. Folded size 105 x 94 mm 
 
Information cards. To replace the set of laminated cards and in discussion with pharmacists, 
we identified four topics for information cards to be handed out by pharmacists to patients: 
‘Completing your antibiotic course’, ‘Do you need antibiotics?’, ‘Concerns about side effects’ 
and ‘Taking antibiotics with or without food’. These were designed as one-third A4 cards, 
with English on one side, and Kinyarwanda on the other. (Figure 7) 




Figure 7. Information leaflets for patients with English on one side and Kinyarwanda on the other. 210 x 99 
mm 
 
Set of posters. At the request of workshop participants, keen to promote BBM, a series of 
posters with key messages was introduced to the campaign. As part of the discussion at the 
workshop, participants were shown a range of illustrative styles: photographs, schematic 
images and drawings. A style of drawing used in one of the IDAPPS winning entries, Good 
Bugs, Bad Bugs, was picked out by the workshop participants as being appropriate in terms 
of level of formality and visual interest. As a result, a set of illustrations was commissioned 
and the illustrator was asked to work from a series of photographs supplied by RCPU to 
ensure authenticity in people’s appearance and dress, and context of use. The posters had 
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messages for pharmacists: ‘Your pharmacist can advise you about whether you need 
antibiotics or not’; ‘Your pharmacists will advise whether you should take antibiotics with or 
without food’ and ‘Pharmacists in Rwanda are working to prevent and control antibiotic 
resistance’; and for patients, ‘Make sure you complete your course of antibiotics; ‘If side 
effects bother you or won’t go away, speak to your pharmacist or doctor and they will advise 
you what to do’. The posters were designed in A4 format, and as with the information cards, 
has Kinyarwanda on one side and English on the other. (Figure 8) 
 
Figure 8. Two of the series of posters. English on one side, Kinyarwanda on the other. 297 x 210 mm 
 
Information for pharmacists. To accompany the antibiotic record card, the information 
cards and the posters, an ‘Information for pharmacists’ leaflet explained the purpose of these 
materials and how to use them. It also contained a clear explanation, ‘What is antibiotic 
resistance? for pharmacists to share with their patients.  
 
All the materials were included in a pack (Figure 9) for distribution by RCPU to 20 
pharmacies in Kigali for user evaluation. To support their conversations, each pilot 
pharmacy was provided with 280 antibiotic record cards and 560 information leaflets. The 
pharmacists were briefed through an introductory video that explained what the materials 
were for and how the data should be captured. Pharmacists were asked to record via a simple 
tally the number of antibiotic prescriptions they issued each day of the 10-day pilot study. 
They were asked to record the length of time they spent speaking with patients about 
antibiotics: less that 5 minutes; between 5 and 10 minutes; and more than 1o minutes. The 
pharmacists were also asked for feedback about their experience of using the materials. 
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Fourteen of the 20 pharmacies took part in the pilot study. Three pharmacies used all the 
record cards they had been given, and on average 65% of the antibiotic record cards were 
used during the pilot, and 74% of the information leaflets. This usage suggests that the 
materials made a significant contribution to the conversation to raise awareness of AMR. All 
the pharmacists agreed that it was helpful to have materials about antibiotics to give to 
customers. Eleven out of 14 pharmacies found that more than half the time it was easy to 
have a conversation about AMR with their patients. Thirteen participants said that they 
discussed AMR during the pilot more than they usually did. 
 
Figure 9. Components of the pack of materials for evaluation for distribution to pharmacies in Kigali. 
 
The materials were praised by pharmacists as a way of starting conversations about 
antibiotic resistance. They welcomed time efficiencies by being able to convey messages 
about using antibiotics through clearly presented cards that fitted inside prescription bags. 
One pharmacist remarked: “All pharmacies should get these cards so that more patients can 
get them” and “I did realize that most of my clients are interested in respecting the 
instructions we gave after being aware of the effect of not taking antibiotics correctly. I would 
recommend this pilot to be expanded to up country pharmacies where there is also a large 
number of people who lack information about effective use of antibiotics.” Feedback from 
RCPU was that their involvement in BBM has raised the status of community pharmacists 
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and that it helped to “empower our members and pharmacy professionals to provide our 
clients (patients) high-quality service and keep antibiotics working.”  
The success of the pilot led to requests by CPA and RCPU for more widespread 
distribution in Rwanda and in other CPA membership countries. This introduced another 
design challenge. The pilot materials had been professionally printed in the UK and had been 
designed to take advantage of, for example, ability to bleed off color at the edges of the paper 
or card. The printing had been funded as part of the research project, with recognition that 
sources of funding would need to be found for future production. Given that we could not 
assume that any professional printing would be funded to enable widespread use in Rwanda, 
we produced a new set of BBM materials for printing on desktop printers and assumed that 
paper (rather than card) would be used. This was done in consultation with pharmacists 
most of whom said they had access to a desktop printer. To keep costs low, therefore, the 
antibiotic card was revised to fit on one side of A4 (with no bleed) so it could be folded as a 
‘two sheets of paper thick’ object that same size as the original; the information cards were 
designed to fit on A4 sheets concertina folded. Step-by-step instructions for printing and 
folding the antibiotic record card and patient information cards were included (Figure 10). 
These revised materials were made available via the CPA website, and RCPU also used their 
website and an instructional webinar for dissemination.  
 
Figure 10. The antibiotic card designed for printing on a desktop printer and instructions for folding. 
 
5. Challenges, benefits and opportunities 
The project brought operational challenges that might be expected, such as distribution of 
funding, and timeliness of producing funder requirements such as Memoranda of 
Understanding. There were unanticipated expectations, such as that of pharmacists 
collaborating in the project workshops wanting a certificate from the University of Reading 
to affirm their attendance, of the Rwandan researchers that funding would continue beyond 
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the end of the project, and of the UK team that it would be straightforward to send funding 
and print research materials to Rwanda.  
However, such challenges were far outweighed by the mutual benefits of 
collaboration across disciplines and international borders. The value of participatory design 
(or co-design) in relation to health communication has been well-evidenced in the 
information design literature (e.g. Zender et al., 2017; Black et al., 2017; Waller & 
VandenBerg, 2017), as well as in design for health more broadly (see Donetto et al., 2015). In 
this project, our partners CPA and RCPU had never been engaged in the process of designing 
-- or indeed thought that they were relevant to it. To realize that design is about solving a 
problem without a predetermined outcome was a revelation -- the more so because they 
became aware of the value and power of design to enable action, and to work towards 
solutions that are relevant for stakeholders and users. A positive outcome of the kind of 
partnership working in this project was that those with no experience of design process or 
practice were convinced of the value of designing, of what design could do, and ambition to 
make a difference. 
However, one of the project challenges was eliciting feedback. While the pharmacists 
in our pilot were keen to use the materials, only 14/20 pharmacies responded to our 
questionnaire despite written and video protocols. In future work, therefore, we will be 
mindful of the need to explain the importance and relevance of feedback. More informal 
feedback, such as comments from workshop participants and project team members was 
easier to capture.  
For the BBM materials, the design brief was compiled in the participatory design 
workshops. In the workshops, stakeholders worked with the research team to determine the 
messages and modes of information about AMR and its distribution and use in community 
pharmacies. Our non-design colleagues contributed to the work in many ways. An early 
decision was to produce material in single language rather than dual-language form for 
reasons of clarity and ease of use, and translation from English to Kinyarwanda was 
undertaken by pharmacists. The illustrator (drawing was preferred to photographs or 
schematic images after discussions in a workshop) worked from source material collated by 
attendees at one of the workshops in Rwanda. The design brief was taken by professional 
designers and transformed into materials/artefacts taking account of production and 
distribution issues, and the application of research-informed practice with regard to 
legibility and structure of information. We were therefore able to introduce non-designers to 
the details of visual organization that contribute to ease of reading, such as use of headings 
and lists to structure the text, typographic differentiation of key messages, and use of color to 
differentiate information for different kinds of use by identifying these in relation to the 
antibiotic record card. We used the workshops and discussions about the materials to draw 
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attention to usefulness of list structures, of highlighting key messages, easy-to-understand 
headings and other features as shown, for example, in the antibiotic record card illustrated 
in Figure 6. 
In this project, design practice and design research were inter-related. Designing the 
artefacts was iterative, demonstrated by the different versions shown in this paper through 
changes in wording (as ‘microbes’ instead of ‘bugs’), and in the format and folding of the 
materials. The project also highlighted that compromise to optimal visual quality is 
sometime necessary to ensure that important messages reach as large an audience as 
possible. The version of the antibiotic record card for widespread distribution (via CPA and 
RCPU website) was redesigned with a surrounding white border (for ease of printing) which 
is arguably less visually strong than the version bled off on all sides. However, such 
pragmatic solutions can secure user-engagement that might not otherwise occur. To ensure 
wide dissemination of this resource, it was important to have a version that could be printed 
on a home printer, with instructions for folding the paper so that it could function in the way 
that the original printed card did. 
Moving forward, colleagues in Rwanda and other LMICs are keen to continue the 
work and to extend the approach to other health concerns. They are keen for advice both on 
design process and on the ‘look and feel’ of artefacts. There has been mention of ‘toolkits’, 
‘guidelines’ and ‘templates’, and we are still considering an appropriate way forward. We are 
more inclined towards principles (e.g. Lentz et al., 2014) rather than detailed 
recommendations (e.g. Lonsdale et al., 2019), but a key message will be to engage with all 
stakeholders and users, involve designers at the beginning of any communication project, 
and consider carefully how to act on any feedback. As information designers we would not be 
inclined to compromise on clarity of language and legibility, but we recognize that less than 
optimal solutions may be necessary to make sure access to information is as wide as possible. 
One next step for any successful pilot project is to think about ways of upscaling. To 
this end we have worked with the CPA, which has made the downloadable BBM materials 
available on its website.  In Rwanda, we have had interest from pharmaceutical wholesale 
distributors in sponsoring printing; and given the widespread use of mobile phones in 
Rwanda, and in response to feedback, we are considering an on-line version of the antibiotic 
record card, and subject to the availability of screens in pharmacies, a video of key messages 
about antibiotics, using the BBM ‘brand’. 
An unexpected BBM legacy has been continued cross-disciplinary collaboration 
between the members of the project team. Project partner Design Science subsequently 
collaborated with a bio-medical scientist (workshop attendee) on an Innovate UK funded 
project in India, ‘Milk Guard’ (https://milk-guard.com/)  to help treat mastitis and reduce 
AMR in cows and buffalo.  Design-led collaboration between IDAPPS team members (bio-
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science and information design) has stimulated a new project about instructional text for 
COVID home- and community- testing kits, recently funded by the UK Research and 
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